These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 25322077

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease.
    Nanetti L, Contarino VE, Castaldo A, Sarro L, Bachoud-Levi AC, Giavazzi M, Frittoli S, Ciammola A, Rizzo E, Gellera C, Bruzzone MG, Taroni F, Grisoli M, Mariotti C.
    Parkinsonism Relat Disord; 2018 Jun; 51():17-23. PubMed ID: 29496355
    [Abstract] [Full Text] [Related]

  • 25. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR, TRACK-HD Investigators.
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [Abstract] [Full Text] [Related]

  • 26. Hybrid 2-[18F] FDG PET/MRI in premanifest Huntington's disease gene-expansion carriers: The significance of partial volume correction.
    Hellem MNN, Vinther-Jensen T, Anderberg L, Budtz-Jørgensen E, Hjermind LE, Larsen VA, Nielsen JE, Law I.
    PLoS One; 2021 Jul; 16(6):e0252683. PubMed ID: 34115782
    [Abstract] [Full Text] [Related]

  • 27. Regional subcortical shape analysis in premanifest Huntington's disease.
    Tang X, Ross CA, Johnson H, Paulsen JS, Younes L, Albin RL, Ratnanather JT, Miller MI.
    Hum Brain Mapp; 2019 Apr 01; 40(5):1419-1433. PubMed ID: 30376191
    [Abstract] [Full Text] [Related]

  • 28. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease.
    Sturrock A, Laule C, Decolongon J, Dar Santos R, Coleman AJ, Creighton S, Bechtel N, Reilmann R, Hayden MR, Tabrizi SJ, Mackay AL, Leavitt BR.
    Neurology; 2010 Nov 09; 75(19):1702-10. PubMed ID: 21060093
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA, van der Burg JM, Landwehrmeyer GB, Brundin P, Stijnen T, EHDI Study Group, Roos RA.
    Neurology; 2008 Nov 04; 71(19):1506-13. PubMed ID: 18981372
    [Abstract] [Full Text] [Related]

  • 31. Bradykinesia in early Huntington's disease.
    Sánchez-Pernaute R, Künig G, del Barrio Alba A, de Yébenes JG, Vontobel P, Leenders KL.
    Neurology; 2000 Jan 11; 54(1):119-25. PubMed ID: 10636136
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Extrastriatal degeneration correlates with deficits in the motor domain subscales of the UHDRS.
    Galvez V, Ramírez-García G, Hernandez-Castillo CR, Bayliss L, Díaz R, Lopez-Titla MM, Campos-Romo A, Fernandez-Ruiz J.
    J Neurol Sci; 2018 Feb 15; 385():22-29. PubMed ID: 29406908
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Basal ganglia-cortical structural connectivity in Huntington's disease.
    Novak MJ, Seunarine KK, Gibbard CR, McColgan P, Draganski B, Friston K, Clark CA, Tabrizi SJ.
    Hum Brain Mapp; 2015 May 15; 36(5):1728-40. PubMed ID: 25640796
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
    Simmons DA, James ML, Belichenko NP, Semaan S, Condon C, Kuan J, Shuhendler AJ, Miao Z, Chin FT, Longo FM.
    Hum Mol Genet; 2018 Aug 15; 27(16):2893-2912. PubMed ID: 29860333
    [Abstract] [Full Text] [Related]

  • 40. Microglial activation in presymptomatic Huntington's disease gene carriers.
    Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P.
    Brain; 2007 Jul 15; 130(Pt 7):1759-66. PubMed ID: 17400599
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.